INTERVIEWS

Discussions with top medical experts on key issues of the day.

Page 1 of 11

« start ‹ previous ... 1 2 3 4 5 ... next › end »

Update on Triple Negative Breast Cancer

Kathy Miller, MD, 2012 May 22, Interview by L Scott Zoeller

Dr. Miller is Associate Professor and Sheila D. Ward Scholar, Department of Medicine Division of Hematology/Oncology, Indiana University School of Medicine. OncologySTAT: What is known at this point about...

Antiangiogenic Therapy In Breast Cancer—What We Know and What We Don't

Kathy Miller, MD, 2012 May 2, Interview by L Scott Zoeller

Dr. Miller is Associate Professor and Sheila D. Ward Scholar, Department of Medicine Division of Hematology/Oncology, Indiana University School of Medicine. OncologySTAT: Results of recent analyses have...

Endpoints Explained—Part II

Dan Sargent, MD, 2012 Apr 23, Interview by L Scott Zoeller

Daniel J. Sargent, PhD, is the Ralph S. and Beverly E. Caulkins Professor of Cancer Research at the Mayo Clinic Cancer Center in Rochester, Minnesota, and Group Statistician for the Alliance for Clinical...

Duration of Anti-VEGF Therapy Is Key in Metastatic Colorectal Cancer

Axel Grothey, MD, 2012 Apr 13, Interview by L Scott Zoeller

OncologySTAT: What is the evidence for and against the use of bevacizumab in combination with first-line chemotherapy for metastatic colorectal cancer (CRC)?Dr. Grothey: When bevacizumab was initially...

An Opportunity to Prevent Acute Leukemia Relapse

Isabel Cunningham, MD, 2012 Apr 11, Interview by L Scott Zoeller

OncologySTAT: Would you tell us about your research investigating extramedullary leukemic tumors? Dr. Cunningham: The lack of real improvement in the cure rates of acute leukemia and creation of completely...

Dr. Victor Grann on Ethnic Neutropenia

Victor Grann, MD, 2012 Mar 29, Interview by L Scott Zoeller

Victor R. Grann, MD, MPH, is Clinical Professor of Medicine and Epidemiology and Health Policy & Management, College of Physicians & Surgeons and Mailman School of Public Health at Columbia University...

How Being a Patient Has Changed Me As a Doctor

Mark Lewis, MD, 2012 Feb 16, Interview by L Scott Zoeller

OncologySTAT: You were diagnosed with multiple endocrine neoplasia type 1 (MEN 1) during your hematology/oncology fellowship at the Mayo Clinic. How long ago was that, and would you tell us a little about...

Dr. Andre Goy: Update on the Use of R-CHOP in Diffuse Large B-Cell Lymphoma

Interview by L Scott Zoeller, 2012 Jan 26, OncologySTAT Editorial Team

OncologySTAT: Would you give an update on treatment of early-stage diffuse large B-cell lymphoma (DLBCL)? Would you discuss the data surrounding the optimal number of cycles of rituximab (R) plus cyclophosphamide,...

Dr. David Henry: It Just Keeps Getting Better and Better in Myeloma

David Henry, MD, 2012 Jan 25, Interview by L Scott Zoeller

To mark 2011, we have asked our distinguished OncologySTAT Advisory Board Members to choose their top story of the year. In this interview, Dr. David Henry discusses his choice for this year in myeloma....

Dr. Clifford Hudis: 2011 Top Stories in Breast Cancer—Chemoprevention, Novel Agents, Less Surgery

Clifford Hudis, MD, 2012 Jan 24, Interview by L Scott Zoeller

To mark 2011, we have asked our distinguished OncologySTAT Advisory Board Members to choose their top story of the year. In this interview, Dr. Clifford Hudis discusses his choice for this year in breast...